This compound helps eye cells fight stress for a few hours, but after a full day, it stops working—so it won’t help if the damage lasts too long.
Scientific Claim
Brosimine B does not significantly alter catalase activity in avian retinal cells after 24 hours of oxygen-glucose deprivation, indicating that its antioxidant-enhancing effects are transient and may not sustain protection during prolonged ischemic stress.
Original Statement
“After 24 h of OGD, catalase activity was similarly decreased in both treated (63.30% ± 14.36%) and untreated groups (67.20% ± 7.85%), compared to controls (100.00% ± 20.40%), with no significant difference (ns, p > 0.05).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The absence of effect is statistically reported as non-significant; the claim accurately reflects the data without overinterpreting the mechanism.
Evidence from Studies
Supporting (0)
Contradicting (1)
Brosimine B and the biphasic dose-response: insights into hormesis and retinal neuroprotection
The study found that Brosimine B helps protect eye cells from damage during oxygen and sugar shortage by boosting natural antioxidant defenses, including catalase — so it does work, and it works for at least 24 hours, contrary to the claim.